Figure 2. Overall survival according to PIK3CA mutation status in cohort 2.
In cohort 2, overall survival was not significantly different between patients with PIK3CA-mutant tumors (black) and those with PIK3CA wild-type tumors (gray) (p = 0.416).
In cohort 2, overall survival was not significantly different between patients with PIK3CA-mutant tumors (black) and those with PIK3CA wild-type tumors (gray) (p = 0.416).